Literature DB >> 263340

Plasma immunoreactive relaxin levels in pregnant and nonpregnant women.

E M O'Byrne, B T Carriere, L Sorensen, A Segaloff, C Schwabe, B G Steinetz.   

Abstract

Immunoreactive relaxin was measured in plasma samples obtained from human volunteers utilizing the RIA procedure of Sherwood et al., as modified by O'Byrne and Steinetz for heterologous plasma samples. Immunoreactive hormone was not detected in samples obtained from men, and only rarely in plasma of nonpregnant women. Immunoreactive relaxin was present as early as the fourth week of pregnancy and was detectable throughout the course of gestation. Immunoreactive relaxin tended to be higher early in pregnancy, and there was no peak just before parturition as occurs in many other species. Our results are at variance with those of Bryant and coworkers, who reported high levels of immunoreactive relaxin in men and nonpregnant as well as pregnant women. The possible reasons for this discrepancy are presented.

Entities:  

Keywords:  Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods; Endocrine System; Examinations And Diagnoses; Family Planning; Hormones--analysis; Laboratory Examinations And Diagnoses; Laboratory Procedures; Men; Menopause; Menstrual Cycle; Menstruation; Oral Contraceptives; Physiology; Pregnancy; Pregnancy, First Trimester; Pregnancy, Second Trimester; Pregnancy, Third Trimester; Reproduction; Reproductive Control Agents; Women

Mesh:

Substances:

Year:  1978        PMID: 263340     DOI: 10.1210/jcem-47-5-1106

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  The relaxin-like factor is a hormone.

Authors:  E E Büllesbach; R Rhodes; B Rembiesa; C Schwabe
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

2.  Potential influence of the corpus luteum on circulating reproductive and volume regulatory hormones, angiogenic and immunoregulatory factors in pregnant women.

Authors:  Kirk P Conrad; Georgia M Graham; Yueh-Yun Chi; Xiaoman Zhai; Minjie Li; R Stan Williams; Alice Rhoton-Vlasak; Mark S Segal; Charles E Wood; Maureen Keller-Wood
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-08-13       Impact factor: 4.310

Review 3.  Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia.

Authors:  Kirk P Conrad
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

Review 4.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

5.  The occurrence of relaxin in hyperstimulated human preovulatory follicles collected in an in vitro fertilization program.

Authors:  H Yki-Järvinen; T Wahlström; A Tenhunen; A I Koskimies; M Seppälä
Journal:  J In Vitro Fert Embryo Transf       Date:  1984-09

6.  Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies.

Authors:  Kirk P Conrad; Valerie L Baker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-24       Impact factor: 3.619

7.  Localization of relaxin in human gestational corpus luteum.

Authors:  P Mathieu; J Rahier; K Thomas
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

8.  Protection from cigarette smoke-induced vascular injury by recombinant human relaxin-2 (serelaxin).

Authors:  Alessandro Pini; Giulia Boccalini; Maria Caterina Baccari; Matteo Becatti; Rachele Garella; Claudia Fiorillo; Laura Calosi; Daniele Bani; Silvia Nistri
Journal:  J Cell Mol Med       Date:  2016-02-24       Impact factor: 5.310

Review 9.  Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases.

Authors:  Alana Aragón-Herrera; Sandra Feijóo-Bandín; Laura Anido-Varela; Sandra Moraña-Fernández; Esther Roselló-Lletí; Manuel Portolés; Estefanía Tarazón; Oreste Gualillo; José Ramón González-Juanatey; Francisca Lago
Journal:  J Pers Med       Date:  2022-06-21

Review 10.  Relaxin as a natural agent for vascular health.

Authors:  Daniele Bani
Journal:  Vasc Health Risk Manag       Date:  2008
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.